2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 25452462)

Published in Eur Heart J on December 01, 2014

Authors

Stavros V Konstantinides

Associated clinical trials:

CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients (InShapeIII) | NCT03083093

Intraoperative Goal-directed Blood Pressure and Dexmedetomidine | NCT03933306

Articles by these authors

Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32

Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice. Arterioscler Thromb Vasc Biol (2006) 1.49

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2. Thromb Haemost (2007) 0.84

Expression of the leptin receptor in different types of vascular lesions. Histochem Cell Biol (2007) 0.83

Update on the cardiovascular risk in obesity: endocrine and paracrine role of the adipose tissue. Hellenic J Cardiol (2011) 0.83

Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice. Thromb Haemost (2007) 0.83

Management of acute pulmonary embolism: a contemporary, risk-tailored approach. Hellenic J Cardiol (2010) 0.79

Fibrinolysis for intermediate-risk pulmonary embolism. N Engl J Med (2014) 0.78

Progress in the management of acute pulmonary embolism. Curr Opin Pulm Med (2015) 0.77

Recurrent venous thromboembolism: quite harmless after all? Thromb Haemost (2008) 0.75

External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism. Thromb Haemost (2017) 0.75

Venous thromboembolism: Past, present and future. Thromb Haemost (2017) 0.75